Research Topic

$150M is not enough: Canada’s proposed Purdue Pharma settlement for opioid damages is paltry and won’t prevent future crises
While the largest settlement of a governmental healthcare cost claim in Canadian history, it's also a paltry amount compared to the approximately US$6 billion Purdue will pay in the United States.
Federal government invests $10 million in initiative to assess outpatient treatments for COVID-19
The federal government announced it will invest $10 million to research outpatients medications for COVID-19 through the Can-ADAPT COVID research platform.

Half-hour online training session helps teenagers deal with academic-related stress: study

U.S. researchers suggest it could be delivered across the country.
Ivano Bioscience wins Mitacs award for time-saving lab kits

Ivano Bioscience has won an award for its innovative work: time-saving lab test kits that contain bioengineered artificial cells and viruses already inside them.
Ontario likely in new COVID wave driven by BA.5 subvariant, science table says

Dr. Fahad Razak, scientific director of the group, says the highly infectious BA.5 variant also appears to be more immune evasive, meaning people who were recently infected can catch the virus again soon after.
Gabapentin increasingly involved in drug overdose deaths

Nearly 90% of drug overdose deaths in which gabapentin was detected also involved an opioid, particularly illicitly manufactured fentanyl.
Germany's CureVac files suit against vaccine rival BioNTech

German biotech company CureVac said Tuesday it has filed a patent infringement lawsuit against rival BioNTech for work that it says contributed to the development of the BioNTech-Pfizer coronavirus vaccine.
'Permanent bone loss': Calgary study finds astronauts suffer on return to Earth

A study released Thursday from the Cumming School of Medicine at the University of Calgary followed 17 astronauts before and after their space flights.
Cannabis use worsens bipolar disorder and major depressive disorder

CANMAT advises against cannabis use in patients with bipolar disorder or major depressive disorder.
How well does previous infection with COVID-19, MIS-C protect against Omicron?

Previous infections protect against other variants but not Omicron, while vaccination does offer protection.

$150M is not enough: Canada’s proposed Purdue Pharma settlement for opioid damages is paltry and won’t prevent future crises

Federal government invests $10 million in initiative to assess outpatient treatments for COVID-19

Half-hour online training session helps teenagers deal with academic-related stress: study

Ivano Bioscience wins Mitacs award for time-saving lab kits

Ontario likely in new COVID wave driven by BA.5 subvariant, science table says

Gabapentin increasingly involved in drug overdose deaths

Germany's CureVac files suit against vaccine rival BioNTech

'Permanent bone loss': Calgary study finds astronauts suffer on return to Earth

Cannabis use worsens bipolar disorder and major depressive disorder

How well does previous infection with COVID-19, MIS-C protect against Omicron?